Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+259.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+259.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
46.4x
Strong expansion
Streak
6 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 440.70% |
| 2024 | 114.55% |
| 2023 | 40.95% |
| 2022 | 9.51% |
| 2021 | -49.04% |
| 2020 | -126.30% |
| 2019 | -10452.82% |
| 2018 | 0.00% |